What is the appropriate starting dose of metoprolol (β‑1‑selective blocker) for an adult patient, including those with mild obstructive airway disease?

Starting Dose of Metoprolol

For oral metoprolol tartrate, start with 25-50 mg every 6-12 hours, even in patients with mild obstructive airway disease, using the lower end (12.5-25 mg) for those with respiratory concerns. 1

Dosing by Clinical Context

Acute Coronary Syndrome (STEMI/NSTEMI)

Intravenous followed by oral:

• IV: 5 mg slow IV push over 1-2 minutes, repeated every 5 minutes for up to 3 doses (total 15 mg maximum) 1, 2, 3, 2, 4
• Oral transition: 15 minutes after last IV dose, start 25-50 mg every 6 hours for 48 hours 1, 2, 3, 2
• Maintenance: Transition to 100 mg twice daily after 48 hours, titrating up to 200 mg daily as tolerated 1

Oral-only initiation (when IV not indicated or safety concerns exist):

• Start 25-50 mg orally within first 24 hours 1
• Use lower doses (25 mg or even 12.5 mg) if concerns about tolerance 2, 3, 2

Hypertensive Emergencies

For acute severe hypertension requiring IV therapy, esmolol is preferred over metoprolol due to its ultra-short half-life and titratable nature 5. If metoprolol is used: 5 mg IV over 1-2 minutes, repeated every 5 minutes up to 15 mg total 6.

Supraventricular Tachycardia

IV metoprolol: 2.5-5 mg IV bolus over 2 minutes, can repeat in 10 minutes up to 3 doses 6

Critical Considerations for Obstructive Airway Disease

Patients with mild COPD or reactive airway disease can receive metoprolol, but require specific precautions:

• Use reduced starting dose: 12.5 mg orally rather than complete avoidance 2, 3, 2
• Ensure optimal bronchodilator therapy with selective β2-agonists is in place before initiating 7
• Maximum safe dose: Do not exceed 100 mg total daily dose in asthmatics 7
• Monitor closely for increased dyspnea, wheezing, or need for rescue bronchodilators 2, 3, 2

The evidence shows metoprolol at doses ≤100 mg daily does not significantly affect FEV1 in stable patients with mild-moderate obstructive disease when concurrent bronchodilator therapy is optimized 7, 8, 9. However, higher doses (200 mg daily) can precipitate bronchospasm 7.

Absolute Contraindications to Beta-Blockers

Do not initiate metoprolol if any of the following are present 1, 2, 3, 2, 1:

• Signs of heart failure (rales, S3 gallop)
• Evidence of low output state (oliguria)
• Increased risk for cardiogenic shock (age >70, SBP <120 mmHg, HR >110 or <60 bpm)
• PR interval >0.24 seconds
• Second- or third-degree AV block without pacemaker
• Active asthma or severe reactive airways disease
• Sinus bradycardia (HR <50 bpm)
• Hypotension (SBP <90 mmHg)

Important Caveats

Recent trial data (2026) showed metoprolol 100 mg daily did not reduce COPD exacerbations in patients without cardiovascular disease and was associated with modest early reductions in lung function 10, 11. This reinforces that beta-blockers should only be used in COPD patients when there is a clear cardiovascular indication (post-MI, heart failure, etc.), not for COPD management itself 12.

Hepatic impairment: Start at low doses with cautious titration as metoprolol levels increase substantially 4

Elderly patients: Use lower initial starting doses given decreased hepatic/renal function 4

Target heart rate: Aim for resting HR 50-60 bpm unless limiting side effects occur 2, 3, 2